

Is Clindamycin still in shortage in 2026? Get the latest update on availability, cost, and what patients can do to find Clindamycin in stock.
If you've been prescribed Clindamycin and heard the words "back order" or "out of stock," you're probably wondering what's going on — and how long this will last. Drug shortages are stressful, especially when you need an antibiotic to fight an active infection.
This article gives you the latest information on the Clindamycin shortage in 2026, explains what's been causing the supply problems, and gives you practical steps to get your medication filled.
As of early 2026, the shortage picture for Clindamycin looks like this:
In short: the shortage primarily affects injectable Clindamycin used in hospitals and clinical settings. If you take oral capsules or use a topical form, you should be able to find your medication, though you may need to check more than one pharmacy.
The Clindamycin shortage has been driven by several overlapping factors:
The injectable shortage has been ongoing intermittently since 2021. Manufacturers like Sagent have had production issues with their 150 mg/mL vials, and Pfizer has experienced delays with Cleocin injectable products. When major manufacturers can't produce enough, the entire market feels the squeeze.
Like many generic injectable drugs, Clindamycin Phosphate Injection is made by only a handful of companies. When even one manufacturer goes down, there aren't enough others to pick up the slack. This is a systemic problem in the U.S. generic drug market.
When hospitals can't get injectable Clindamycin, some providers switch patients to oral capsules where clinically appropriate. This increased demand on the oral supply chain can cause temporary stock-outs at retail pharmacies.
Raw material sourcing, shipping delays, and quality control requirements can all slow production. These global supply chain challenges have affected many generic medications, not just Clindamycin.
One piece of good news: Clindamycin is a widely available generic, and the cost is generally affordable for most patients.
Most insurance plans — including Medicare Part D and Medicaid — cover generic Clindamycin as a Tier 1 or Tier 2 medication with low copays, typically $0-$15. Prior authorization is generally not required.
For more ways to save, read: How to Save Money on Clindamycin in 2026: Coupons, Discounts, and Patient Assistance.
While no brand-new Clindamycin formulations have been approved recently, a few developments are worth noting:
If your pharmacy is out of Clindamycin, here are your best options:
Medfinder lets you check which pharmacies near you have Clindamycin in stock. Enter your medication and zip code to see results — it's the fastest way to avoid the pharmacy runaround.
Independent pharmacies often use different distributors and may have stock when chain pharmacies don't. Compounding pharmacies can also prepare custom Clindamycin formulations if needed.
If your regular pharmacy doesn't have it on the shelf, ask if they can order it. For oral capsules, many distributors can deliver within 1-2 business days.
If you truly can't find Clindamycin, talk to your doctor about alternatives like Azithromycin, Doxycycline, or Metronidazole. Learn more: Alternatives to Clindamycin If You Can't Fill Your Prescription.
Use our step-by-step guide: How to Check If a Pharmacy Has Clindamycin in Stock.
The Clindamycin shortage in 2026 is real — but it primarily affects injectable forms used in hospitals. Oral capsules, topical products, and vaginal formulations are generally available, even if you may need to shop around a bit.
Stay proactive: use Medfinder to search for stock, talk to your doctor about alternatives if needed, and don't delay treatment for an active infection. The situation is improving as manufacturers work to resolve production issues, and the FDA continues to monitor supply.
For a full overview of the medication, see: What Is Clindamycin? Uses, Dosage, and What You Need to Know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.